EXPERIMENTAL AND MOLECULAR MEDICINE
Scope & Guideline
Pioneering discoveries in biochemistry and molecular biology.
Introduction
Aims and Scopes
- Molecular Mechanisms of Disease:
Focuses on the molecular pathways involved in various diseases, including cancer, metabolic disorders, and neurodegenerative diseases, providing insights into potential therapeutic targets. - Experimental Models and Techniques:
Utilizes diverse experimental models, including organoid systems, animal models, and advanced imaging techniques, to investigate disease mechanisms and test therapeutic interventions. - Translational Research:
Emphasizes the translation of laboratory findings into clinical applications, bridging the gap between basic science and clinical practice, particularly in oncology and regenerative medicine. - Immunology and Inflammation:
Explores the roles of immune responses and inflammation in disease progression and therapy, with a focus on therapeutic strategies that modulate immune pathways. - Genomics and Epigenetics:
Investigates the impact of genomic and epigenetic alterations on disease development and progression, employing cutting-edge sequencing technologies to elucidate complex biological processes. - Microbiome and Disease Interactions:
Examines the interactions between the microbiome and host physiology, particularly how these interactions influence disease states and therapeutic outcomes. - Advanced Therapeutics and Drug Development:
Covers innovative approaches in drug discovery, including the development of novel therapeutic agents, biomarker identification, and personalized medicine strategies.
Trending and Emerging
- Organoid Technology and Applications:
The use of organoids as models for disease research is rapidly expanding, allowing for more accurate studies of human physiology and disease mechanisms, as well as drug testing. - Targeted Cancer Therapies:
There is a growing focus on developing targeted therapies that exploit specific molecular pathways in cancer, reflecting advances in precision medicine. - RNA Biology and Therapeutics:
Research on the roles of non-coding RNAs, including microRNAs and long non-coding RNAs, is trending, with implications for cancer therapy and gene regulation. - Immunotherapy and Immune Modulation:
The exploration of novel immunotherapeutic strategies, including the manipulation of immune pathways and the development of immune checkpoint inhibitors, is gaining momentum. - Metabolic Reprogramming in Disease:
Research into how metabolic changes affect disease progression, particularly in cancer and metabolic disorders, is emerging as a critical area of study. - Microbiome Research and Health:
The investigation of the microbiome's role in health and disease is increasingly prominent, with implications for therapeutic interventions and understanding disease mechanisms. - Epigenetics and Disease:
The study of epigenetic modifications and their impact on gene expression and disease development is on the rise, highlighting the complexity of genetic regulation.
Declining or Waning
- Traditional Pharmacology:
Research focused on classical pharmacological approaches is less prevalent, as more emphasis is placed on targeted therapies and personalized medicine. - Basic Biochemistry:
While foundational biochemistry remains important, there is a noticeable shift towards more complex systems biology and molecular mechanisms, leading to a decline in studies centered solely on basic biochemical processes. - In vitro Cell Culture Studies:
The reliance on conventional in vitro studies has decreased, with a growing preference for more sophisticated models, such as organoids and 3D cultures, which better mimic in vivo conditions. - Animal Models of Disease:
The use of traditional animal models is declining in favor of more innovative and relevant models that can better replicate human disease mechanisms and responses to treatments. - Single Biomarker Studies:
Research focusing on single biomarkers is becoming less common as the field shifts towards integrative approaches that consider multiple factors and interactions within biological systems.
Similar Journals
Byulleten Sibirskoy Meditsiny
Unlocking Insights in Molecular Biology and TherapeuticsByulleten Sibirskoy Meditsiny, published by the Siberian State Medical University, is a pivotal open-access journal in the field of Molecular Medicine, with its current edition indexed under the ISSN 1682-0363. Since its transition to open access in 2013, the journal aims to disseminate high-quality research and advancements in biomedical sciences, particularly focusing on molecular mechanisms and therapeutic interventions. Despite its relatively recent recognition in Molecular Medicine, where it ranks in the 6th percentile, the journal is dedicated to fostering knowledge exchange and collaboration among researchers, professionals, and students alike. With a modest impact factor and quarterly publication, Byulleten Sibirskoy Meditsiny is positioned to serve as a valuable resource for those engaged in the intricate realms of molecular biology, biochemistry, and general medicine, contributing to the broader scientific discourse in the Russian Federation and beyond.
Experimental and Therapeutic Medicine
Empowering the medical community with pivotal insights.Experimental and Therapeutic Medicine is a distinguished peer-reviewed journal published by SPANDIDOS PUBL LTD, focusing on the dynamic fields of Immunology, Microbiology, and Cancer Research. With its ISSN 1792-0981 and E-ISSN 1792-1015, this journal holds a notable position in the research community, contributing valuable insights into experimental methodologies and therapeutic strategies that advance understanding in these critical areas. Although the journal's coverage in Scopus was discontinued after 2018, it continues to serve as a resource for emerging studies and novel discoveries, evidenced by its ranking within the 37th percentile in Immunology and Microbiology, and the 17th percentile in Cancer Research. Researchers, professionals, and students alike can benefit from its rigorous articles and comprehensive reviews, further enhancing their comprehension of the vibrant landscape of modern medicine. Explore this journal to discover pivotal findings that shape the future of healthcare.
Current Molecular Pharmacology
Connecting Researchers to Cutting-edge Pharmacological InsightsCurrent Molecular Pharmacology, published by Bentham Science Publishers, is a prominent journal focused on the dynamic fields of pharmacology, drug discovery, and molecular medicine. With an ISSN of 1874-4672 and an E-ISSN of 1874-4702, this journal aims to disseminate cutting-edge research and review articles that showcase innovative methodologies and groundbreaking findings from 2008 through 2024. Holding a respectable Q3 category ranking in Drug Discovery, Molecular Medicine, and Pharmacology for 2023, Current Molecular Pharmacology serves as an essential platform for both established researchers and emerging scholars to share their insights. The journal is indexed in Scopus with its relevant ranks catering to pharmacology and molecular biology, ensuring it reaches a wide array of professionals, researchers, and students in the field. As a contributor to advancing pharmacological sciences, this journal provides invaluable access to the latest advancements and fosters ongoing dialogue in molecular pharmacology, positioning itself as a key resource in the exploration of therapeutic agents and their interactions.
Biochemistry Moscow-Supplement Series B-Biomedical Chemistry
Advancing Biomedical Insights, One Study at a Time.Biochemistry Moscow-Supplement Series B-Biomedical Chemistry, published by MAIK NAUKA-INTERPERIODICA, is a pivotal journal in the fields of biochemistry, clinical biochemistry, and molecular medicine. Established in 2008, the journal serves as a vital platform for researchers and professionals seeking to disseminate and access groundbreaking research in the biomedical sciences. With an ISSN of 1990-7508 and an E-ISSN of 1990-7516, the journal has been recognized in the Q4 quartile across various categories as of 2023, highlighting its emerging presence in the academic community despite a competitive landscape. Although currently not available as Open Access, the journal encompasses a broad spectrum of studies, ranging from theoretical analysis to practical applications in biomedical research. The journal's dedicated focus on advancing our understanding of biochemical principles positions it as an essential resource for students and professionals alike, enhancing its significance in the global scientific dialogue.
FASEB BioAdvances
Transforming Insights into Impactful ResearchFASEB BioAdvances, published by WILEY, is an esteemed open-access journal dedicated to advancing the fields of biochemistry, molecular biology, and physiology. Since its inception in 2019, the journal has rapidly established a significant presence within the academic community, boasting an impressive impact factor reflective of its Q2 and Q3 standings across various categories, including Biochemistry, Genetics and Molecular Biology, Cancer Research, Molecular Medicine, and Physiology. The journal aims to disseminate high-quality research and innovative findings to enhance the understanding of biological processes, making it a vital resource for researchers, professionals, and students alike. With its commitment to open access, FASEB BioAdvances ensures that groundbreaking research is available to a global audience, facilitating collaboration and exploration in these rapidly evolving scientific domains.
MedComm is a distinguished Open Access journal published by Wiley, located in the United States. Since its inception in 2020, it has rapidly established itself as a leading platform for cutting-edge research in the fields of Biochemistry, Cell Biology, Drug Discovery, Genetics, Immunology and Allergy, and Oncology, achieving a prestigious Q1 category ranking across multiple disciplines in 2023. MedComm is committed to providing a rigorous and transparent peer-review process, ensuring the publication of high-quality articles that advance the frontiers of medical science. With its remarkable Scopus ranking, the journal serves as an invaluable resource for researchers, professionals, and students looking to stay abreast of important developments in the life sciences. The open access model facilitates widespread dissemination of scholarly work, fostering collaboration and innovation within the global scientific community. Researchers interested in submitting their work or exploring the latest findings are encouraged to engage with this pivotal journal during the converged years from 2020 to 2024.
Autophagy
Bridging Fundamental Discoveries with Clinical InsightsAutophagy is a premier peer-reviewed journal published by Taylor & Francis, Inc. in the United States, focusing on advances in the fields of Cell Biology and Molecular Biology. With an impressive impact factor reflected in its Q1 ranking in both categories, Autophagy stands as a vital resource for researchers and professionals dedicated to understanding the intricate mechanisms of cellular degradation and recycling. The journal has been a cornerstone of scientific communication since its inception in 2005, continuing to flourish through 2024, fostering collaboration and innovation in the study of autophagic processes. Although it does not currently offer Open Access options, the journal remains highly regarded for its rigorous peer-review process and its commitment to publishing high-quality, impactful research. By bridging fundamental research with clinical applications, Autophagy plays a crucial role in advancing our understanding of various diseases, making it an essential tool for scholars and practitioners in the biomedical field.
BIOMEDICAL RESEARCH-TOKYO
Advancing Biomedical Knowledge Since 1980BIOMEDICAL RESEARCH-TOKYO is an esteemed interdisciplinary journal published by BIOMEDICAL RESEARCH PRESS LTD, dedicated to disseminating pioneering research and advancements in the fields of biochemistry, genetics, and medicine. Since its inception in 1980, the journal has established itself as a reputable source of knowledge, contributing significantly to the global scientific community with its strong emphasis on innovative findings and methodologies. With a consistent presence in the Q3 quartile for both Biochemistry, Genetics and Molecular Biology and Medicine categories as of 2023, it continues to attract a diverse range of research articles. While the journal does not operate as an open access platform, it remains an essential resource for researchers, professionals, and students seeking to further their understanding of biomedical sciences. Located in Sapporo, Japan, this journal fosters collaboration and knowledge sharing among the international biomedical research community, engaging readers through its compelling studies that span from 1980 to 2024.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
Unraveling the Molecular Mysteries of DiseaseBIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, published by Elsevier, is a pivotal journal in the fields of Molecular Biology and Molecular Medicine, recognized for its high impact factor and robust ranking within Scopus categories, holding prestigious quartiles in Q1 for both disciplines as of 2023. With ISSN 0925-4439 and E-ISSN 1879-260X, this journal fosters cutting-edge research from 1990 to 2025, addressing the critical molecular mechanisms underlying human diseases. Its wide-ranging scope includes original research articles, reviews, and advanced theoretical insights, serving as an essential resource for researchers, clinicians, and students alike. The journal is based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, and while it does not currently offer an open-access option, it continues to maintain a strong presence in the scientific community, enhancing our understanding of molecular processes in health and disease.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
Illuminating Pathways in Experimental ResearchINTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, published by Wiley, is a leading peer-reviewed journal dedicated to the field of experimental pathology. With an ISSN of 0959-9673 and E-ISSN 1365-2613, the journal has been a vital resource for researchers and professionals since its inception in 1990, covering a broad spectrum of topics within pathology, cell biology, and molecular biology. The journal's relevancy is underscored by its Q2 ranking in Pathology and Forensic Medicine and Q3 rankings in both Cell Biology and Molecular Biology, as of 2023, reflecting its significant contribution to the scientific community. Although it does not currently offer open access options, readers can benefit from its insightful research articles and reviews that guide advancements in diagnostic pathology and therapeutic strategies. As the journal continues to evolve, it remains committed to facilitating the exchange of innovative ideas and findings that drive progress in experimental pathology and related fields, making it an indispensable platform for scientists, clinicians, and students alike.